B Effector Cells Activated by a Chimeric Protein Consisting of IL-2 and the Ectodomain of TGF- Receptor II Induce Potent Antitumor Immunity

Cancer Research- United States

doi 10.1158/0008-5472.can-11-1659

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of Antitumor Immunity by B Cells

Cancer Research
Cancer ResearchOncology
2007English

Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice

Clinical Cancer Research
Cancer ResearchOncology
2009English

Dendritic Cells Combined With Tumor Cells and Α-Galactosylceramide Induce a Potent, Therapeutic and NK-cell Dependent Antitumor Immunity in B Cell Lymphoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Regulatory B Cells Inhibit Antitumor Immunity

Cancer Research
Cancer ResearchOncology
2007English

In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18

Journal of Immunology
AllergyImmunology
2003English

Potent Induction of (1,3)-Fucosyltransferase VII in Activated CD4+ T Cells by TGF- 1 Through a P38 Mitogen-Activated Protein Kinase-Dependent Pathway

Journal of Immunology
AllergyImmunology
2000English

TGF- Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction

Journal of Immunology
AllergyImmunology
2008English

T Regulatory-1 Cells Induce IgG4 Production by B Cells: Role of IL-10

Journal of Immunology
AllergyImmunology
2005English

Effector-Like CD8+ T Cells in the Memory Population Mediate Potent Protective Immunity

Immunity
Infectious DiseasesAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy